A safe and effective medication designed to prevent mild-to-moderate COVID-19 infections from becoming more dangerous has been available for almost two years. But recent studies have shown many patients eligible for the drug—Paxlovid—haven't ...
Apr 1, 2024
0
1
Medulloblastoma (the most common malignant childhood brain tumor) is separated into four molecular groups, with Group 3 bearing the worst prognosis. By studying EP300 and CBP, critical proteins in Group 3 medulloblastoma ...
Apr 25, 2024
0
11
For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6 in Circulation to coincide with the ...
Apr 8, 2024
0
0
Patients in the UK and European Union are facing shortages of vital medicines such as antibiotics and epilepsy medication, research published Thursday found.
Apr 18, 2024
0
0
Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.
Apr 23, 2024
0
25
A specific genetic alteration, known as an ALK fusion, drives non-small cell lung cancer in some patients. This abnormality leads to excessive activity of the ALK protein, a key cancer promoter. These tumors can be treated ...
Apr 16, 2024
0
26
Alzheimer's disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly 13 million by 2050, the lack of meaningful therapies represents a major unmet medical need. Scientists ...
Apr 16, 2024
0
0
A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization ...
Apr 25, 2024
0
35
All prescription drugs need a license from a regulator to treat a specific condition. But licensed drugs can be prescribed for conditions they haven't been tested for in a clinical trial. This is known as "off-label" prescribing—and ...
Mar 27, 2024
0
1
Whether it's costs, safety risks, or "pill fatigue" they're trying to reduce, many health systems and clinics have started working on ways to encourage the deprescribing of medications that patients may not need.
Apr 11, 2024
0
0
